IP Library Granted Patent US 8,865,232
Granted Patent B2
US 8,865,232 · App. 13/856,638 · Granted Oct 21, 2014

Method for treating ocular

Inventors: Ying-Ying Gao (Quanzhou, CN); Scheffer Tseng (Pinecrest, FL)
Assignee: TissueTech, Inc.
A61K9/70A61K36/61A61K36/23A61K31/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,232
App. No.
13/856,638
Granted
Oct 21, 2014
Kind
B2
Abstract

The present invention relates to a method for treating a disorder chosen from ocular Demodex, Demodex -induced blepharitis, rosacea, acne, and meibomian gland dysfunction in a patient in need thereof, comprising administering to the patient a compositions comprising a therapeutically effective amount of a substance chosen from at least one of an isoprenoidal essential oil such as Tea Tree Oil; Terpinen-4-ol; (+)-Carvone; alpha-Terpineol; Cardinene; d-Carvone; 1-Carvone; gamma-Terpinene; alpha-Terpinene; 1,8-Cineole; alpha-Terpineol; para-Ci mene; alpha-Pinene; Limonene; (R)-(+)-Limonene; alpha-Thugene; Eucalyptol; (+)-Ledene; Cuminic Aldehyde; and Myrcene; the administration comprising contacting or scrubbing an affected area of skin or hair, or eyelid margin and lashes of the patient with the composition; also disclosed are a method for treating mange and mite infestations on a mammalian animal; and kits for in-office and at home treatments of the disorders.

Claims (20)

1. A cleaning device comprising (a) a sterile towel; and (b) a solution consisting essentially of terpinen-4-ol as an active agent and one or more pharmaceutically-acceptable excipients, wherein the solution does not include tea tree oil.

2. The cleaning device of claim 1 , wherein the one or more pharmaceutically-acceptable excipients are selected from water, saline, corn oil, olive oil, glycerol, petroleum jelly, dextrose, ethanol, or a combination thereof.

3. The cleaning device of claim 1 wherein the one or more pharmaceutically-acceptable excipients is water, glycerol or a combination thereof.

4. The cleaning device of claim 1 , wherein the terpinen-4-ol is present in an amount effective to treat a Demodex infection in a subject in need thereof.

5. The cleaning device of claim 4 , wherein the amount of terpinen-4-ol effective to treat a Demodex infection in a subject in need thereof is between about 1 microgram/day to about 1 gram/day.

6. The cleaning device of claim 5 , wherein the Demodex infection is an ocular Demodex infestation or Demodex -induced blepharitis.

7. A method of cleaning the skin of an individual, comprising contacting the skin of the individual with the cleaning device of claim 1 .

8. The method of claim 7 , wherein contacting the skin of the individual with the cleaning device comprises scrubbing the skin with the cleaning device.

9. The method of claim 7 , wherein contacting the skin of the individual with the cleaning device comprises washing the skin with the cleaning device.

10. The method of claim 7 , wherein the skin comprises a face, eye, eyelid, eyelid margin, eyelash, eyelash roots or a combination thereof.

11. The method of claim 7 , wherein the cleaning device further comprises one or more pharmaceutically-acceptable excipients.

12. The method of claim 11 , wherein the one or more pharmaceutically-acceptable excipients are selected from water, saline, corn oil, olive oil, glycerol, petroleum jelly, dextrose, ethanol, or a combination thereof.

13. The method of claim 11 , wherein the one or more pharmaceutically-acceptable excipients comprise water, glycerol or a combination thereof.

14. The method of claim 7 , comprising contacting the skin of the individual with the cleaning device for at least 4 weeks.

15. The method of claim 7 , comprising contacting the skin of the individual with the cleaning device daily.

16. The method of claim 7 , comprising contacting the skin of the individual with the cleaning device twice daily.

17. The method of claim 7 , comprising contacting the skin of the individual with the cleaning device weekly.

18. The method of claim 7 , wherein the therapeutically effective amount of terpinen-4-ol is between about 1 microgram/day to about 1 gram/day.

19. The method of claim 7 , wherein said cleaning comprises treating an ocular Demodex infestation or Demodex -induced blepharitis in the individual.

20. The method of claim 7 , wherein the individual is refractory to an anti-inflammatory, conventionally anti-microbial antibiotic, or an anti-allergy therapy for ocular Demodex infestation or Demodex -induced blepharitis.

Assignments (9)
SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Jun 23, 2023
From: PRN PHYSICIAN RECOMMENDED NUTRICEUTICALS, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 064074/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2023
From: ACUMEN HEALTH HOLDINGS
To: PRN PHYSICIAN RECOMMENDED NUTRICEUTICALS, LLC
Reel/Frame 063937/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2023
From: BIOTISSUE HOLDINGS INC.
To: ACUMEN HEALTH HOLDINGS, LLC
Reel/Frame 063937/0142 →
CHANGE OF NAME Recorded May 10, 2023
From: TISSUETECH, INC.
To: BIOTISSUE HOLDINGS INC.
Reel/Frame 063591/0802 →
RELEASE OF SECURITY INTEREST Recorded May 4, 2023
From: MIDCAP FUNDING IV TRUST
To: TISSUETECH, INC.
Reel/Frame 063540/0567 →
RELEASE OF SECURITY INTEREST Recorded May 4, 2023
From: MIDCAP FINANCIAL TRUST
To: TISSUETECH, INC.
Reel/Frame 063540/0575 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - TERM LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060116/0413 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - REVOLVING LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 060116/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2013
From: GAO, YING-YING; TSENG, SCHEFFER C.G.
To: TISSUETECH, INC.
Reel/Frame 030171/0083 →
Continuity (4)
Continuation 13181767 · Jul 13, 2011
Division 11911956
Provisional Application 60676692 · Apr 30, 2005
Related Publication 20130344128A1 · Dec 26, 2013